Icaritin and lenvatinib treatment for unresectable localized progressive pancreatic cancer: a report of six cases
Background Pancreatic cancer is very difficult to detect in its early stages, and its rapid progression and poor prognosis make it a significant therapeutic challenge. Existing treatment modalities, whether standalone or combined, offer limited efficacy, highlighting an urgent need for more effectiv...
Saved in:
| Main Authors: | Xiaolong Liu, Jianguo Lu, Xinyu Dong, Yizhuo Zhang, Guixing Jiang, Yanlong Cao, Defei Hong |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Annals of Medicine |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/07853890.2025.2512436 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Involvement of icaritin in the regulation of osteocyte exosomal microRNAs
by: Kaijia Zhang, et al.
Published: (2025-02-01) -
First‐Line Treatment of Icaritin and Thalidomide in a Patient With Hepatocellular Carcinoma With PR: A Case Report
by: Zaiyong Jin, et al.
Published: (2025-03-01) -
Discovery and validation of CREB1 as a transcription target of icaritin: Implications for the treatment of depressive-like behavior
by: Ling Gu, et al.
Published: (2025-03-01) -
Icaritin Represses Autophagy to Promote Colorectal Cancer Cell Apoptosis and Sensitized Low‐Temperature Photothermal Therapy via Targeting HSP90‐TXNDC9 Interactions
by: Dan He, et al.
Published: (2025-05-01) -
Efficacy, safety, and biomarker analysis of TACE combined with lenvatinib plus sintilimab in unresectable hepatocellular carcinoma: a real-world study
by: Lingzhan Meng, et al.
Published: (2024-11-01)